dc.contributor.author | Boyers, D. | |
dc.contributor.author | Jia, X. | |
dc.contributor.author | Jenkinson, D. | |
dc.contributor.author | Mowatt, G. | |
dc.date.accessioned | 2013-02-04T11:27:48Z | |
dc.date.available | 2013-02-04T11:27:48Z | |
dc.date.issued | 2012-01-01 | |
dc.identifier | 18170257 | |
dc.identifier | f6403e64-933f-4ea3-84df-207ebc2737d3 | |
dc.identifier | 84861070229 | |
dc.identifier.citation | Boyers , D , Jia , X , Jenkinson , D & Mowatt , G 2012 , ' Eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura : A NICE single technology appraisal ' , Pharmacoeconomics , vol. 30 , no. 6 , pp. 483-495 . https://doi.org/10.2165/11591550-000000000-00000 | en |
dc.identifier.issn | 1170-7690 | |
dc.identifier.uri | http://hdl.handle.net/2164/2585 | |
dc.description | Copyright 2012 Elsevier B.V., All rights reserved. | en |
dc.format.extent | 13 | |
dc.format.extent | 151728 | |
dc.language.iso | eng | |
dc.relation.ispartof | Pharmacoeconomics | en |
dc.subject | RM Therapeutics. Pharmacology | en |
dc.subject.lcc | RM | en |
dc.title | Eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura : A NICE single technology appraisal | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.2165/11591550-000000000-00000 | |
dc.date.embargoedUntil | 2013-01-01 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=84861070229&partnerID=8YFLogxK | en |